Differential Accumulation of Hypericin in Spheroids Composed of T-24 Transitional Cell Carcinoma Cells Expressing Different Levels of E-Cadherin

Journal of Urology

Volumn 179, Issue 5, 2008, Pages 2014-2019

  Huygens, Ann ^a   Crnolatac, Ivo ^a   Develter, Jan ^a   Van Cleynenbreugel, Ben ^b   Van der Kwast, Theo ^c   de Witte, Peter A M ^a  

^a Faculteit Farmaceutische Wetenschappen   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

administration, intravesical; bladder; cadherins; carcinoma, transitional cell; hypericin

Indexed keywords

HYPERICIN; MESSENGER RNA; UVOMORULIN;

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL CLONE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACCUMULATION; FETAL CALF SERUM; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPHEROID CELL; TRANSITIONAL CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; CADHERINS; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; CLONE CELLS; HUMANS; PERYLENE; PHOTOSENSITIZING AGENTS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 41749119144     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.12.038     Document Type: Article

References (23)

1. Tyczynski J.E., and Parkin D.M. Bladder cancer in Europe. Eur Netw Cancer Reg 3 (2003) 1
2. Borden L.S., Clark P.E., and Hall M.C. Bladder cancer. Curr Opin Urol 15 (2003) 227
3. Dolmans D.E., Fukumura D., and Jain R.K. Photodynamic therapy for cancer. Nat Rev Cancer 3 (2003) 380
4. Pinthus J.H., Bogaards A., Weersink R., Wilson B.C., and Trachtenberg J. Photodynamic therapy for urological malignancies: past to current approaches. J Urol 175 (2006) 1201
5. D'Hallewin M.A., Kamuhabwa A.R., Roskams T., de Witte P.A.M., and Baert L. Hypericin-based fluorescence diagnosis of bladder carcinoma. BJU Int 89 (2002) 760
6. Olivo M., Lau W., Manivasager V., Tan P.H., Soo K.C., and Cheng C. Macro-microscopic fluorescence of human bladder cancer using hypericin fluorescence cystoscopy and laser confocal microscopy. Int J Oncol 23 (2003) 983
7. D'Hallewin M.A., Baert L., and Vanherzeele H. In vivo fluorescence detection of human bladder carcinoma without sensitizing agents. J Am Paraplegia Soc 17 (1994) 161
8. Kiesslich T., Krammer B., and Plaetzer K. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr Med Chem 13 (2006) 2189
9. Bindels E.M.J., Vermey M., van den Beemd R., Dinjens W.N.M., and Van der Kwast T.H. E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ. Cancer Res 60 (2000) 177
10. Imao T., Koshida K., Endo Y., Uchibayashi T., Sasaki T., and Namiki M. Dominant role of E-cadherin in the progression of bladder cancer. J Urol 161 (1999) 692
11. Okegawa T., Li Y., Pong R.C., and Hsieh J.T. Cell adhesion proteins as tumor suppressors. J Urol 167 (2002) 1836
12. Huygens A., Kamuhabwa A.R., Roskams T., Van Cleynenbreugel B., Van Poppel H., and de Witte P.A.M. Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cells. J Urol 174 (2005) 69
13. Falk H., and Oberreiter M. A convenient semisynthetic route to hypericin. Monatsh Chem 124 (1993) 339
14. Mazur Y., and Meruelo D. Ion pairs of hypericin compounds having antiviral activity. Patent Cooperation Treaty (1993) WO 93/15607
15. Hudson M.A. When intravesical measures fail. Indication for cystectomy in superficial disease. Urol Clin North Am 19 (1992) 601
16. Jichlinski P., and Leisinger H.J. Photodynamic therapy in superficial bladder cancer: past, present and future. Urol Res 29 (2001) 396
17. Popov Z., Gil-Diez de Medina S., Lefrere-Belda M.A., Hoznek A., Bastuji-Garin S., Abbou C.C., et al. Low-E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information. Br J Cancer 83 (2000) 209
18. Delaey E.M., Obermueller R., Zupko I., de Vos D., Falk H., and de Witte P.A. In vitro study of the photocytotoxicity of some hypericin analogs on different cell lines. Photochem Photobiol 74 (2001) 164
19. Lavie G., Mazur Y., Lavie D., Prince A.M., Pascual D., Liebes L., et al. Hypericin as an inactivator of infectious viruses in blood components. Transfusion 35 (1995) 392
20. Huygens A., Crnolatac I., Maes J., Van Cleynenbreugel B., Van Poppel H., Roskams T., et al. Influence of the glycosaminoglycan layer on the permeation of hypericin in rat bladders in vivo. BJU Int 100 (2007) 1176
21. Guo X., Rao J.N., Liu L., Zou T.T., Turner D.J., Bass B.L., et al. Regulation of adherens junctions and epithelial paracellular permeability: a novel function for polyamines. Am J Physiol Cell Physiol 285 (2003) C1174
22. Kucharzik T., Walsh S.V., Chen J., Parkos C.A., and Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 159 (2001) 2001
23. Falk H., and Meyer J. On the homo- and heteroassociation of hypericin. Monatsh Chem 125 (1994) 753